Upregulation of FOXM1 in a subset of relapsed myeloma results in poor outcome

被引：16

作者：

Gu, Chunyan ^{[1
,2
]}

Holman, Carol ^{[2
]}

Sompallae, Ramakrishna ^{[2
,3
]}

Jing, Xuefang ^{[2
]}

Tomasson, Michael ^{[4
,5
]}

Hose, Dirk ^{[6
]}

Seckinger, Anja ^{[6
]}

Zhan, Fenghuang ^{[4
,5
]}

Tricot, Guido ^{[4
,5
]}

Goldschmidt, Hartmut ^{[6
,7
]}

Yang, Ye ^{[1
,8
]}

Janz, Siegfried ^{[2
,5
]}

机构：

[1] Nanjing Univ Chinese Med, Affiliated Hosp 3, Nanjing 210023, Jiangsu, Peoples R China

[2] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Pathol, Iowa City, IA 52242 USA

[3] Univ Iowa, Roy J & Lucille A Carver Coll Med, Iowa Inst Genet, Iowa City, IA 52242 USA

[4] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA

[5] Univ Iowa, Roy J & Lucille A Carver Coll Med, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA

[6] Univ Klinikum Heidelberg, Med Klin 5, D-69120 Heidelberg, Germany

[7] Natl Ctr Tumorerkrankungen, D-69120 Heidelberg, Germany

[8] Nanjing Univ Chinese Med, Minist Educ, Key Lab Acupuncture & Med Res, Nanjing 210023, Jiangsu, Peoples R China

来源：

BLOOD CANCER JOURNAL | 2018年 / 8卷

基金：

中国国家自然科学基金;

关键词：

THERAPEUTIC TARGET; PD-0332991; INHIBITION; BORTEZOMIB; GENES; CELLS;

D O I：

10.1038/s41408-018-0060-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：5

共 15 条

[1]

[Anonymous], SEMIN CANC BIOL

[2] A novel orally active small molecule potently induces G1 arrest in primary myeloma cells and prevents tumor growth by specific inhibition of cyclin-dependent kinase 4/6 [J].

Baughn, Linda B. ;

Di Liberto, Maurizio ;

Wu, Kaida ;

Toogood, Peter L. ;

Louie, Tracey ;

Gottschalk, Rachel ;

Niesvizky, Ruben ;

Cho, Hearn ;

Ely, Scott ;

Moore, Malcolm A. S. ;

Chen-Kiang, Selina .

CANCER RESEARCH, 2006, 66 (15) :7661-7667

[3] Elucidation and Pharmacological Targeting of Novel Molecular Drivers of Follicular Lymphoma Progression [J].

Bisikirska, Brygida ;

Bansal, Mukesh ;

Shen, Yao ;

Teruya-Feldstein, Julie ;

Chaganti, Raju ;

Califano, Andrea .

CANCER RESEARCH, 2016, 76 (03) :664-674

[4] Identification of FOXM1 as a therapeutic target in B-cell lineage acute lymphoblastic leukaemia [J].

Buchner, Maike ;

Park, Eugene ;

Geng, Huimin ;

Klemm, Lars ;

Flach, Johanna ;

Passegue, Emmanuelle ;

Schjerven, Hilde ;

Melnick, Ari ;

Paietta, Elisabeth ;

Kopanja, Dragana ;

Raychaudhuri, Pradip ;

Mueschen, Markus .

NATURE COMMUNICATIONS, 2015, 6

[5]

Fry DW, 2004, MOL CANCER THER, V3, P1427

[6] The prognostic landscape of genes and infiltrating immune cells across human cancers [J].

Gentles, Andrew J. ;

Newman, Aaron M. ;

Liu, Chih Long ;

Bratman, Scott V. ;

Feng, Weiguo ;

Kim, Dongkyoon ;

Nair, Viswam S. ;

Xu, Yue ;

Khuong, Amanda ;

Hoang, Chuong D. ;

Diehn, Maximilian ;

West, Robert B. ;

Plevritis, Sylvia K. ;

Alizadeh, Ash A. .

NATURE MEDICINE, 2015, 21 (08) :938-945

[7] FOXM1 is a therapeutic target for high-risk multiple myeloma [J].

Gu, C. ;

Yang, Y. ;

Sompallae, R. ;

Xu, H. ;

Tompkins, V. S. ;

Holman, C. ;

Hose, D. ;

Goldschmidt, H. ;

Tricot, G. ;

Zhan, F. ;

Janz, S. .

LEUKEMIA, 2016, 30 (04) :873-882

[8] Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma [J].

Hose, Dirk ;

Reme, Thierry ;

Hielscher, Thomas ;

Moreaux, Jerome ;

Messner, Tobias ;

Seckinger, Anja ;

Benner, Axel ;

Shaughnessy, John D., Jr. ;

Barlogie, Bart ;

Zhou, Yiming ;

Hillengass, Jens ;

Bertsch, Uta ;

Neben, Kai ;

Moehler, Thomas ;

Rossi, Jean Francois ;

Jauch, Anna ;

Klein, Bernard ;

Goldschmidt, Hartmut .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (01) :87-95

[9] Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single-agent activity in patients with relapsed multiple myeloma [J].

Kumar, Shaji K. ;

LaPlant, Betsy ;

Chng, Wee Joo ;

Zonder, Jeffrey ;

Callander, Natalie ;

Fonseca, Rafael ;

Fruth, Briant ;

Roy, Vivek ;

Erlichman, Charles ;

Stewart, A. Keith .

BLOOD, 2015, 125 (03) :443-448

[10] A novel therapeutic combination using PD 0332991 and bortezomib: Study in the 5T33MM myeloma model [J].

Menu, Eline ;

Garcia, Josefina ;

Huang, Xiangao ;

Di Liberto, Maurizio ;

Toogood, Peter L. ;

Chen, Isan ;

Vanderkerken, Karin ;

Chen-Kiang, Selina .

CANCER RESEARCH, 2008, 68 (14) :5519-5523

← 1 2 →